Nanette Cocero - May 8, 2023 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role
Director
Signature
/s/ Paul Bavier, Attorney-in-fact
Stock symbol
HLVX
Transactions as of
May 8, 2023
Transactions value $
$0
Form type
4
Date filed
5/10/2023, 05:41 PM
Next filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLVX Stock Option (Right to Buy) Award $0 +34K $0.00 34K May 8, 2023 Common Stock 34K $14.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest and become exercisable in substantially equal monthly installments over three years, commencing on May 8, 2023, subject to the reporting person's continued service on the board of directors of the Issuer through each such vesting date..